| Literature DB >> 27757386 |
Taewoong Oh1, Sakura Tanaka2, Tatsuki Naka3, Shoji Igawa2.
Abstract
PURPOSE: This study was performed to assess the effects of high-intensity intermittent swimming training(HIT) on bone in ovariectomized rats.Entities:
Keywords: Bone; High-intensity exercise; Ovariectomized rat; Swimming training
Year: 2016 PMID: 27757386 PMCID: PMC5067419 DOI: 10.20463/jenb.2016.09.20.3.6
Source DB: PubMed Journal: J Exerc Nutrition Biochem ISSN: 2233-6834
Body mass and composition
| Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Final wt (g) | 296.7 | 10.96 | 289.3 | 6.05 | 366 | 8.87 | 333.9 | 6.68 | 273.3 | 3.62 | 242.3 | 9.94 |
| Food intake (g/day) | 17.4 | 0.62 | 15.8 | 0.54 | 19.0 | 0.97 | 17.3 | 0.50 | 16.2 | 0.89 | 16.7 | 1.80 |
| UW (g) | 0.62 | 0.06 | 0.64 | 0.10 | 0.13 | 0.01 | 0.10 | 0.01 | 0.62 | 0.04 | 0.60 | 0.04 |
| UW/kg wt | 0.21 | 0.02 | 0.23 | 0.03 | 0.04 | 0.00 | 0.03 | 0.00 | 0.24 | 0.01 | 0.25 | 0.03 |
| FW (g) | 8.92 | 1.94 | 6.79 | 0.81 | 14.54 | 1.37 | 8.77 | 1.01 | 5.39 | 0.93 | 2.92 | 1.05 |
| FW/kg wt | 3.01 | 0.61 | 2.44 | 0.26 | 4.10 | 0.33 | 2.73 | 0.29 | 2.07 | 0.35 | 1.24 | 0.38 |
| Soleus/kg wt | 0.04 | 0.00 | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 | 0.01 | 0.04 | 0.00 | 0.04 | 0.00 |
ap < .05 vs S
bp < .05 vs SE
cp < .05 vs O
dp < .05 vs OE
ep < .05 vs OE2
fp < .05 vs OEE
S, sham-operated and sedentary; SE, sham-operated and exercise trained; O, ovariectomized and sedentary; OE, ovariectomized and exercise trained; OE2, ovariectomized and given 17β-estradiol; OEE, ovariectomized, exercise trained, and given 17β-estradiol; Wt, weight; UW, uterine weight; FW, fat weight
Bone weight, bone mineral density (BMD), and breaking strength of the femur (F) and tibia (T)
| Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Femur/kg wt (g) | 0.27 | 0.01 | 0.30 | 0.01 | 0.23 | 0.00 | 0.27 | 0.01 | 0.30 | 0.01 | 0.33 | 0.01 |
| Tibia/kg wt (g) | 0.22 | 0.01 | 0.25[ | 0.01 | 0.19 | 0.00 | 0.23 | 0.00 | 0.25 | 0.01 | 0.27 | 0.01 |
| F-BMD/kg wt (mg/cm2/kg) | 0.08 | 0.00 | 0.09 | 0.00 | 0.07 | 0.00 | 0.07 | 0.00 | 0.09 | 0.00 | 0.10[ | 0.01 |
| T-BMD/kg wt (mg/cm2/kg) | 0.06 | 0.01 | 0.07 | 0.01 | 0.05 | 0.00 | 0.05 | 0.00 | 0.08 | 0.00 | 0.10 | 0.01 |
| F-breaking strength (kg*f) | 6.89 | 0.34 | 7.39 | 0.26 | 5.69 | 0.15 | 7.22 | 0.26 | 7.76 | 0.40 | 7.58 | 0.58 |
| T-breaking strength (kg*f) | 4.83 | 0.30 | 6.10 | 0.20 | 4.11 | 0.14 | 6.14 | 0.25 | 5.24 | 0.22 | 5.79 | 0.26 |
ap < .05 vs S
bp < .05 vs SE
cp < .05 vs O
dp < .05 vs OE
ep < .05 vs OE2
fp < .05 vs OEE
S, sham-operated and sedentary; SE, sham-operated and exercise trained; O, ovariectomized and sedentary; OE, ovariectomized and exercise trained; OE2, ovariectomized and given 17β-estradiol; OEE, ovariectomized, exercise trained, and given 17β-estradiol; Wt, weight
Biochemical markers of bone metabolism and insulin levels
| Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gla-osteocalcin | 39.08 | 6.80 | 37.18 | 1.69 | 52.11 | 1.78 | 47.39 | 3.43 | 21.27 | 2.73 | 15.79 | 0.86 |
| Glu-osteocalcin | 57.71 | 7.69 | 61.99 | 9.77 | 116.57 | 6.00 | 121.52 | 12.30 | 28.94 | 3.73 | 26.29 | 2.88 |
| Gla/Glu-osteocalcin | 0.79 | 0.22 | 0.68 | 0.12 | 0.45 | 0.02 | 0.41 | 0.04 | 0.66 | 0.06 | 0.64 | 0.08 |
| Insulin (μg/L) | 1.14 | 0.32 | 0.55 | 0.18 | 3.26 | 1.46 | 1.41 | 0.21 | 2.27 | 0.50 | 1.87 | 0.61 |
ap < .05 vs S
bp < .05 vs SE
cp < .05 vs O
dp < .05 vs OE
ep < .05 vs OE2
fp < .05 vs OEE
S, sham-operated and sedentary; SE, sham-operated and exercise trained; O, ovariectomized and sedentary; OE, ovariectomized and exercise trained; OE2, ovariectomized and given 17β-estradiol; OEE, ovariectomized, exercise trained, and given 17β-estradiol
Trabecular parameters of the proximal tibia cancellous bone by micro-computed tomography
| Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BV/TV (%) | 10.26 | 0.84 | 19.77 | 3.66 | 4.18 | 0.29 | 10.92 | 1.55 | 7.48 | 0.45 | 8.46 | 0.39 |
| Tb.Th (μm) | 49.66 | 0.97 | 62.44 | 3.38 | 48.81 | 0.75 | 57.76 | 1.87 | 52.99 | 0.91 | 53.27 | 0.83 |
| Tb.N (/mm) | 2.06 | 0.15 | 3.06 | 0.45 | 0.85 | 0.05 | 1.84 | 0.20 | 1.41[ | 0.08 | 1.59 | 0.06 |
| Tb.Sp (μm) | 450.74 | 42.47 | 336.18 | 105.49 | 1170.49 | 89.32 | 535.20 | 49.38 | 666.95 | 40.82 | 581.38 | 24.23 |
| TBPf (/mm) | 12.55 | 0.07 | 7.70 | 0.78 | 7.99 | 0.64 | 6.27 | 0.50 | 5.08 | 0.70 | 5.11 | 0.72 |
ap < .05 vs S
bp < .05 vs SE
cp < .05 vs O
dp < .05 vs OE
ep < .05 vs OE2
fp < .05 vs OEE
S, sham-operated and sedentary; SE, sham-operated and exercise trained; O, ovariectomized and sedentary; OE, ovariectomized and exercise trained; OE2, ovariectomized and given 17β-estradiol; OEE, ovariectomized, exercise trained, and given 17β-estradiol; Wt, weight